ISB News

How Physics and Thermodynamics Help Assess DNA Defects in Cancer

3 Bullets:

  • ‘Big data’ cancer research has revealed a new spectrum of genetic mutations across tumors that need understanding.
  • Existing methods for analyzing DNA defects in cancer are blind to how those mutations actually behave.
  • ISB scientists developed a new approach using physics- and structure-based modeling to systematically assess the spectrum of mutations that arise in several gene regulatory proteins in cancer.

By Jake Valenzuela and Justin Ashworth

A significant challenge in cancer research is having the right tools and methods to analyze the myriad data generated by large-scale projects such as The Cancer Genome Atlas. Existing methods are too statistical and are blind to the way in which mutations actually affect protein function and biophysical mechanisms.

Researchers at Institute for Systems Biology have developed a new method that systematically investigates how small mutations in the DNA sequences that encode proteins result in structural and energetic changes that impact protein function. This study, a collaboration of the Baliga and Shmulevich labs, simulated the physics and energetics of protein structure and function in order to assess the impacts of a broad spectrum of protein mutations that have been observed in human cancers. Specifically, researchers considered mutations in proteins called transcription factors that regulate cellular function in order to predict and identify the putative effects of these mutations on gene expression and cell regulatory pathways.

Title: Structure-based predictions broadly link transcription factor mutations to gene expression changes in cancers
Journal: Nucleic Acids Research
Authors: Justin Ashworth, Brady Bernard, Sheila Reynolds, Christopher L. Plaisier, Ilya Shmulevich, Nitin S. Baliga
Link: http://nar.oxfordjournals.org/content/early/2014/11/05/nar.gku1031.full

Critical losses of protein function in gene regulatory proteins and tumor suppressors can lead to cellular dysregulation and the hallmarks of cancer. Using a physics-based approach to assess the impacts of mutations resulted in higher mechanistic accuracy in determining links between mutations in transcription factors and changes in gene expression. The method also illustrates a quantitative relationship between the relevant thermodynamic impacts of each unique protein mutation and its prevalence in cancerous tissues.

Integrating molecular biophysics and structure-based modeling into systems-based analyses of disease mutations will improve understanding of the molecular genetics of cancers and to interpret the complex data about mutations that are now available.

Read more about ISB’s work with The Cancer Genome Atlas project.

About Dr. Jake Valenzuela and Dr. Justin Ashworth: Jake is a postdoc in the Baliga Lab and a member of the ISB Editorial Board. Justin is postdoc in the Baliga Lab and lead author of the paper.

Recent Articles

  • COVID-19 Vaccines and Boosters Are Essential for Maternal-Fetal Health

    In light of the recent FDA and CDC decision to approve two updated messenger RNA COVID-19 booster shots, it is imperative to alert the pregnant population of the importance and effectiveness of these vaccines and boosters. 

  • 2023 ISB Virtual Microbiome Series

    2023 ISB Virtual Microbiome Series Registration Now Open!

    On October 11-13, 2023, ISB will host a virtual course and symposium on how the ecology of our guts protects us from pathogens. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious person from across the globe.

  • Baliga Postdoctoral Fellow Training

    Genetic Tools Probe Microbial Dark Matter

    ISB researchers Nitin Baliga, Serdar Turkarslan, Mario Arrieta-Ortiz and Yaqiao Li collaborated with the University of Washington to present the first glimpse of the molecular mechanisms behind the unusual lifestyle of a group of tiny microbes called Patescibacteria. The breakthrough was made possible by the discovery of a way to genetically manipulate these bacteria, an advance that has opened a world of possible new research directions.